🔎 Trials Near Me

Akèy › Limfom Selil-T › Massachusetts › Boston

Etid klinik pou Limfom Selil-T nan Boston, MA

9 etid pou Limfom Selil-T ap chèche patisipan nan sit nan ak bò kote Boston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma

Ap rekriteFaz 2
  • Dana-Farber Cancer Institute, Boston
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT04803201

A Study of Ruxolitinib and Duvelisib in People With Lymphoma

Ap rekriteFaz 1
  • Dana Farber Cancer Institute, Boston
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT05010005

A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCL

Ap rekriteFaz 2
  • Dana-Farber Cancer Institute, Boston
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT06854653

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

Ap rekriteFaz 1/2
  • Massachusetts General Hospital, Boston
Laj 18 ak plis · Tout sèks · Mizajou Aug 19, 2026 · NCT04104776

Pembrolizumab and Brentuximab Vedotin in Subjects With Relapsed/Refractory T-cell Lymphoma

Ap rekriteFaz 2
  • Dana Farber Cancer Institute, Boston
Laj 18 ak plis · Tout sèks · Mizajou Jun 11, 2026 · NCT05313243

A Registry for People With T-cell Lymphoma

Ap rekriteEtid obsèvasyon
  • Massachusetts General Hospital (Data Collection Only), Boston
  • Dana Farber Cancer Institute (Data Collection Only), Boston
Tout laj · Tout sèks · Mizajou May 20, 2026 · NCT05978141

MB-105 in Patients With CD5 Positive T-cell Lymphoma

Ap rekriteFaz 2
  • Massachusetts General Hospital, Boston
Laj 18 ak plis · Tout sèks · Mizajou Oct 3, 2025 · NCT06534060

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Ap rekriteFaz 1
  • Dana-Farber Cancer Institute, Boston
Laj 1 a 21 · Tout sèks · Mizajou Dec 6, 2024 · NCT05476770

Etid Limfom Selil-T nan lòt vil

Lòt etid nan Boston

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.